Analytical Chemistry · 2013 · 86 citations · 21 references
Life SciencesBiochemistryAnalytical ChemistryMass Spectrometric AnalysisMetabolomicsMass SpectrometryMass Spectrometry Data AnalysisMass Spectrometry-based MetabolomicsMetabolite IdentificationMetabolomics Data AnalysisUntargeted MetabolomicsFragmentation Pattern AnalysisIsotope Pattern AnalysisMass Spectral InterpretationMass Spectrometry MetabolomicsMetabolite AnalysisMetabolite Data ProcessingPrecursor Mass AssignmentUntargeted Metabolomics Analysis
Mass spectrometry-based metabolomics relies on MS(2) data for structural characterization of metabolites. To obtain the high-quality MS(2) data necessary to support metabolite identifications, ions of interest must be purely isolated for fragmentation. Here, we show that metabolomic MS(2) data are frequently characterized by contaminating ions that prevent structural identification. Although using narrow-isolation windows can minimize contaminating MS(2) fragments, even narrow windows are not always selective enough, and they can complicate data analysis by removing isotopic patterns from MS(2) spectra. Moreover, narrow windows can significantly reduce sensitivity. In this work, we introduce a novel, two-part approach for performing metabolomic identifications that addresses these issues. First, we collect MS(2) scans with less stringent isolation settings to obtain improved sensitivity at the expense of specificity. Then, by evaluating MS(2) fragment intensities as a function of retention time and precursor mass targeted for MS(2) analysis, we obtain deconvolved MS(2) spectra that are consistent with pure standards and can therefore be used for metabolite identification. The value of our approach is highlighted with metabolic extracts from brain, liver, astrocytes, as well as nerve tissue, and performance is evaluated by using pure metabolite standards in combination with simulations based on raw MS(2) data from the METLIN metabolite database. A R package implementing the algorithms used in our workflow is available on our laboratory website ( http://pattilab.wustl.edu/decoms2.php ).
21
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang, David W. White, Bryson D. Bennett et al. · Nature · 2009 · 4.1K citations · Full text
Ludovic Gillet, Pedro Navarro, Stephen Tate et al. · Molecular & Cellular Proteomics · 2012 · 3K citations · Full text
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar, Laila Poisson, Thekkelnaycke M. Rajendiran et al. · Nature · 2009 · 2.2K citations · Full text
Medicine, Cancer Biology, Oncology +16
Colin A. Smith, Grace O Maille, Elizabeth J. Want et al. · Therapeutic Drug Monitoring · 2005 · 2.2K citations
HMDB: a knowledgebase for the human metabolome
David S. Wishart, Craig Knox, An Chi Guo et al. · Nucleic Acids Research · 2008 · 1.9K citations · Full text